Last $1.38 USD
Change Today -0.02 / -1.43%
Volume 25.9K
PRPH On Other Exchanges
Symbol
Exchange
Berlin
As of 8:10 PM 11/21/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark Lebwohl M.D.

Former Member of Scientific Advisory Board of Quigley Pharma Inc, ProPhase Labs, Inc.
AgeTotal Calculated CompensationThis person is connected to 13 board members in 1 different organizations across 5 different industries.

See Board Relationships
----

Background*

Dr. Mark Lebwohl MD serves as Professor of dermatology and Chairman of the department of dermatology at Mount Sinai School of Medicine in New York City. Dr. Lebwohl serves as president of the New York State Society of Dermatology and served as president of the Manhattan Dermatologic Society. Dr. Lebwohl serves as chairman of the Dermatology Section of the New York Academy of Medicine and Psoriasis Task Force of the American Academy of Dermatology (AAD). Dr. Lebwohl served ...

Read Full Background

Corporate Headquarters*

621 North Shady Retreat Road
Doylestown, Pennsylvania 18901

United States

Phone: 215-345-0919
Fax: --

Board Members Memberships*

Former Director
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PRPH:US $1.38 USD -0.02

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Rajat Rai Chief Executive Officer
Akorn, Inc.
$250.0K
Carolyn J. Logan Chief Executive Officer, President and Director
Salix Pharmaceuticals Ltd.
$867.5K
Bruce C. Cozadd Co-Founder, Executive Chairman and Chief Executive Officer
Jazz Pharmaceuticals Public Limited Company
$771.2K
Douglas L. Drysdale Chairman, Chief Executive Officer and President
Pernix Therapeutics Holdings, Inc.
--
Jeffrey M. Yordon Founder, Chairman and Chief Executive Officer
Sagent Pharmaceuticals, Inc.
$615.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PROPHASE LABS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.